GSK, Glenmark Resolve Malaria Drug Patent Dustup
GlaxoSmithKline LLC and Glenmark Generics Ltd. have settled GSK's patent infringement suit over the India-based generic-drug maker's bid to introduce its own version of anti-malaria drug Malarone in the U.S., the...To view the full article, register now.
Already a subscriber? Click here to view full article